Yubo International Biotech Limited (YBGJ)

Market Cap	1.96M -93.5%
Revenue (ttm)	-18.00 -99.4%
Net Income	-1.11M
EPS	-0.01
Shares Out	170.42M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	70,010
Average Volume	147,553
Open	0.0115
Previous Close	0.0115
Day's Range	0.0115 - 0.0115
52-Week Range	0.0079 - 0.1776
Beta	0.73
RSI	37.46
Earnings Date	Mar 31, 2026

About YBGJ

Yubo International Biotech Limited, through its subsidiaries, focuses on the research, development, and application of endometrial stem cells. The company offers healthcare products for respiratory system, skincare products, hair care products, healthy beverages, and male and female personal care products; and stem cell related services, including cell testing and health management consulting services under the VIVCELL brand. Yubo International Biotech Limited is headquartered in Beijing, China.

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• CEO: Yang Wang
• Employees: 18
• Stock Exchange: OTCMKTS
• Ticker Symbol: YBGJ

Financial Performance

In 2024, YBGJ's revenue was $3,470, a decrease of -99.43% compared to the previous year's $604,676. Losses were -$1.78 million, 48.6% more than in 2023.